Is Donanemab a Breakthrough Treatment for Alzheimer’s?
Donanemab, developed by Eli Lilly, is an experimental antibody treatment targeting N3pG amyloid to slow cognitive decline in Alzheimer’s patients. Recently, an FDA advisory group…
Donanemab, developed by Eli Lilly, is an experimental antibody treatment targeting N3pG amyloid to slow cognitive decline in Alzheimer’s patients. Recently, an FDA advisory group…
Giant viruses found on Arctic ice, led by Laura Perini from Aarhus University, can eat algae, potentially slowing ice melting. These viruses, discovered through DNA…
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Indian universities have significantly improved in the QS 2025 Global Rankings, with 61% seeing score increases. IIT Bombay leads in India, ranking 118th globally. Notable…
The 77th World Health Assembly approved a resolution to enhance global organ donation and transplantation. The plan, to be implemented by 2026, emphasizes ethical practices,…
Personalized cancer vaccines, a type of immunotherapy, use DNA sequencing and AI to create patient-specific treatments. Ongoing trials, like the phase 2 mRNA-based melanoma vaccine,…
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.